Dechra has launched a 9g sachet version of its prednisolone treatment, Equisolon, for horses with severe equine asthma.

The oral corticosteroid powder formulation was previously only available in 180g tubs.

Severe equine asthma, which was previously known…

Dechra has launched Equibactin Powder (25mg sulfadiazine and 5mg trimethoprim), a new antibiotic powder designed to help prevent the under-dosing of larger horses being treated for bacterial infections.

Equibactin oral powder comes in a 60g sachet, which…

Dechra Veterinary Products has launched Strangvac, a protein-based strangles vaccine for horses and ponies.

Strangvac has been in development for over 25 years and Dechra says it's the first and only intramuscular vaccine to help protect against strangles…

Dechra, the maker of Mirataz, is hosting a free webinar: ‘Feline pawsative about feline inappetence?’, at 8:00pm tonight.

Presented by Sam Taylor BVetMed(Hons) CertSAM DipECVIM-CA MANZCVS FRCVS, the webinar will also be available to watch on…

Dechra is conducting a survey about strangles to better understand veterinary surgeons' approach to managing the disease.

The survey will assess vets’ experiences of the disease, biosecurity and the role of vaccination to help prevent strangles.…

Dechra has taken over the distribution of two products designed to support kidney health in senior cats, Porus One and its sister product Add One.

Porus One contains renaltec, a selective absorber that absorbs the precursors of uraemic toxins in the cat…

Dechra, maker of Mirataz, is hosting a feline inappetence breakfast meeting at the ISFM Feline Congress at The Clayton Hotel in Dublin at 7.15am on Saturday 1st July to update vets on the practical management of inappetence in cats.

The one hour ‘Wake…

Dechra Academy has launched "Purrfect Partner", a free online CPD series to update and refresh vets on the importance of managing unintended weight loss in feline patients.

The series comprises of six half-hour modules presented by leading European…

Dechra has launched Equisolon Jar, a new presentation of its oral prednisone powder for the treatment of severe equine asthma.

Dechra says Equisolon is the only registered oral prednisolone powder that alleviates the inflammation and clinical parameters…

Dechra (the maker of Vetoryl) has launched 'Prime Suspects', a nationwide campaign to raise awareness of Cushing’s syndrome amongst dog owners and drive them to vet practices for diagnosis and treatment.

The company points to a survey of 1000…

Dechra has launched Cyclofin, an injectable single-dose solution for acute bovine respiratory disease (BRD) caused by oxytetracycline-sensitive Mannheimia (Pasteurella) haemolytica and Pasteurella multocida where an anti-inflammatory and anti-pyretic effect…

Dechra has sponsored two hour-long sessions at this year's Virtual Veterinary Conference 2024, which is free of charge and takes place from Monday 5th to Friday 9th February.

The first, hosted by Sam Taylor, head of veterinary specialists at ISFM (International…

Dechra has launched Pergocoat, for the treatment of Pituitary Pars Intermedia Dysfunction (PPID), aka equine Cushing’s disease.

Pergocoat contains pergolide, a long-acting dopamine receptor agonist.

It is available in 0.5mg (off-white) and 1mg (yellow…

Dechra has launched a Cushing’s treatment and monitoring app to support owners prescribed Vetoryl for their dog.

The free app is designed to help to track changes and improvements in a dog’s health during treatment. 

The app uses questionnaires…

Dechra has launched ‘They’ve got Cushing’s. You’ve got us’ marketing campaign to highlight the company’s support for Vetoryl.

Across Europe, the company has over 30 technical experts who get over 2,500 technical calls…

Dechra has launched Lodisure, a 1mg chicken-flavoured amlodipine tablet for the treatment of feline hypertension. 

Available in packs of 56 (4 x 14 tablet blister packs), Lodisure tablets are divisible for accurate dosing.

The recommended starting dose…

Dechra has launched Furosoral for the initial treatment or maintenance therapy of conditions associated with fluid build-up in cats and dogs.

Furosoral contains furosemide and is indicated for the treatment of hydrothorax, hydropericardium, ascites and…

Dechra is running a series of six 30-45 minute webinars about Cushing's in dogs, starting on Tuesday 10th December.

The webinars will be presented by Professor Ian Ramsey, Ellen Behrend, Joezy Griffin, Professor Jill Maddison and Imogen Schofield.

Dechra has launched Felimazole Oral Solution 5mg/ml (thiamazole) for the stabilisation of hyperthyroidism in cats prior to surgical thyroidectomy and for the long-term treatment of feline hyperthyroidism.

The new presentation is honey-flavoured and is…

Dechra is hosting webinars for vets about strangles and equine disease prevention on Tuesday 18th February and Tuesday 25th February respectively.

The webinars will be available as live podcasts and will also be able to be viewed on demand on the Dechra…

Dechra is hosting ‘The three things about Cushing’s I wish I’d known sooner’, a free one-hour webinar at 7pm on Wednesday 4th June.

The company says the webinar, presented by Dechra veterinary technical advisor, Emily Casey BVM&S…

Dechra is launching a double-divisible version of Vetoryl Flavoured Tablets for dogs with Cushing's.

The range will include Vetoryl 20mg, 30mg and 60mg hydrolysed chicken flavoured tablets, which can be broken into halves or quarters.

The new Vetoryl tablets…

Dechra has expanded its endocrine app with new material on feline hyperthyroidism, with guidance for vets on the diagnosis, treatment, and monitoring of the condition.

The updated content includes instructions on interpreting blood test results and dosing…